25 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Arvinas Competitors or Alternatives

Arvinas's top competitors include Perthera, Pyxis Oncology and IFM Therapeutics.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Arvinas's company profile

Randy Teel

President & CEO

- -
420
$268.4M
$316.7M
  • $268.4M
    $316.7M
  • 420
    $268.4M
  • $316.7M
  • - -
  • 420
  • $268.4M
  • $316.7M
View ProfileView
1
Arvinas's Competitor - Perthera logo

Donna Tuths

President & CEO

82/100
25 - 100
$17.9M
$100K - 5M
  • $17.9M
    $100K - 5M
  • 25 - 100
    $17.9M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $17.9M
  • $100K - 5M
View ProfileView
2
Arvinas's Competitor - Pyxis Oncology logo

Thomas Civik

CEO

- -
60
$342M
$11.5M
  • $342M
    $11.5M
  • 60
    $342M
  • $11.5M
  • - -
  • 60
  • $342M
  • $11.5M
View ProfileView
3
Arvinas's Competitor - IFM Therapeutics logo

H. Martin Seidel

CEO

90/100
25 - 100
$113.5M
$100K - 5M
  • $113.5M
    $100K - 5M
  • 25 - 100
    $113.5M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $113.5M
  • $100K - 5M
View ProfileView
4
Arvinas's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
5
Arvinas's Competitor - Enlivex logo

Oren Hershkovitz

CEO

86/100
36
$315.1M
  • $315.1M
  • 36
    $315.1M
  • 86/100
  • 36
  • $315.1M
View ProfileView
Arvinas' top 14 competitors are Perthera, Pyxis Oncology, IFM Therapeutics, Jounce, NexImmune, Enlivex, Exagen, bluebird bio, Aura, Lycia Therapeutics, Janpix, Ambagon, Prelude Therapeutics and Corvus. Together they have raised over 4.3B between their estimated 1.0K employees. Arvinas has 420 employees and is ranked 1st among it's top 10 competitors. The top 10 competitors average 97.

Arvinas VS Perthera

Perthera is perceived as one of Arvinas's biggest rivals. Perthera was founded in 2012, and its headquarters is in McLean, Virginia. Like Arvinas, Perthera also works within the Pharmaceuticals & Biotechnology field. Perthera has 390 fewer employees than Arvinas.

Arvinas VS Pyxis Oncology

Pyxis Oncology is one of Arvinas's top rivals. Pyxis Oncology is a Public company that was founded in 2019 in Boston, Massachusetts. Like Arvinas, Pyxis Oncology also competes in the Biotechnology sector. Compared to Arvinas, Pyxis Oncology has 360 fewer employees.

Arvinas VS IFM Therapeutics

IFM Therapeutics is Arvinas's #3 rival. IFM Therapeutics is a Private company that was founded in Boston, Massachusetts in 2015. Like Arvinas, IFM Therapeutics also operates in the Biotechnology sector. IFM Therapeutics has 385 fewer employees vs. Arvinas.

Looking for similar companies to Arvinas?

Similar Companies

Pharmaceuticals companies in New Haven

See 12 companies 
Pharmaceuticals companies in Greater Hartford

See 58 companies 
Pharmaceuticals & Biotechnology companies in New Haven

See 37 companies 
Biotechnology companies in New Haven

See 29 companies 
Biotechnology companies in Greater Hartford

See 85 companies 
Companies in Greater Hartford with revenue in $100-500M range

See 87 companies 
Pharmaceuticals companies in Connecticut

See 105 companies 
Biotechnology companies in Connecticut

See 125 companies 
Pharmaceuticals & Biotechnology companies in Greater Hartford

See 133 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Frequently Asked Questions about Arvinas

  1. Who are Arvinas's top competitors?

    Arvinas's top 3 competitors are Perthera, Pyxis Oncology, IFM Therapeutics.

  2. Who is similar to Arvinas?

    Perthera is the most similar to Arvinas. Pyxis Oncology and IFM Therapeutics are also similar to Arvinas.

  1. Are Arvinas and Perthera competitors?

    Yes, Perthera is one of Arvinas’s top competitors.